Report: Former Rite Aid CEO to be released from prison in January
MIAMI Former Rite Aid CEO and chairman Martin Grass is scheduled to be released from a community corrections center in Miami on Jan. 18, according to a report filed Wednesday by the Patriot-News, Rite Aid’s hometown daily newspaper.
Grass is one of six former senior executives charged with overstating Rite Aid earnings in the period before the company’s current management team assumed control of the company in 1999 and embarked on successfully turning the company around.
Grass pleaded guilty to conspiracy to defraud and conspiracy to obstruct justice in June 2003 and agreed to cooperate with the government in the ensuing investigation, the Patriot-News reported.
Generex appoints Rubinfeld as chief scientific adviser
WORCESTER, Mass. One of the original founders of biotech giant Amgen has accepted an advisory position at a company that develops drugs delivered through the inner lining of the mouth.
Generex Biotechnology Corp. announced Tuesday the appointment of Joseph Rubinfeld as chief scientific adviser. The company said Rubinfeld would help the company develop and implement product commercialization plans for its drug delivery platform and synthetic vaccine platform technology programs.
Rubinfeld has worked in pharmaceutical and consumer product development for 50 years. His work has included helping develop the antibiotic amoxicillin and the first synthetic biodegradable detergent.
Becton, Dickinson and Co. to donate insulin injections through Direct Relief
FRANKLIN LAKES, N.J. A company that develops medical devices and technology plans to donate 5 million insulin syringes and pen needles to diabetes patients struggling to manage their disease because of the economic crisis.
Becton, Dickinson and Co. announced a nationwide program Tuesday to distribute the supplies through Direct Relief to more than 1,000 community health centers and free clinics.
“To avoid the debilitating and costly complications of diabetes, patients must effectively manage their conditions,” BD Medical – Diabetes Care president Linda Tharby said in a statement. “Insulin injections often play a vital role in this daily effort, and BD believes that patients who have fallen on tough times should not forego this critical part of their treatment regimen.”